Here are relevant reports on : Pharmaceutical-Drug Delivery Market
-
Home Healthcare Market By Equipment (Oxygen delivery systems, CPAP, nebulizers, ventilators, IV diagnostics, home dialysis, insulin delivery devices, and other equipment)
In this report, we have analyzed how the home healthcare market is evolving. The increasing population above the age group of 65 years covers about 70% of the entire market, while the elderly support population (population between 20-64 years of age) is declining. The lack of family members to support and care for the elderly at home generates a high demand for home care products and services. Along with this, the increased cost of hospital care services presents the largest opportunity for this market. Thus, many companies are eagerly approaching this segment with several customized products and services.
- Published: February 2010
- Price: $ 4950
- TOC Available:
-
Application Delivery Network (ADN) Market [Application delivery controllers (ADC), WAN Optimization controllers (WOC), Application Security Equipments, Application Gateways] Global Advancements, Worldwide Forecasts & Analysis (2013 - 2018)
Mobilization and globalization has forced enterprises to deliver on-demand information that the business requires. Application Delivery Network (ADN) has enabled enterprises to centralize servers, accelerate applications and provide security to web-based application interfaces.
- Published: August 2013
- Price: $ 4950
- TOC Available:
-
Content Delivery Network Market by Component (Solutions (Web Performance Optimization, Media Delivery, Cloud Security) and Services), Content Type (Static and Dynamic), Provider Type, Application Area and Region - Global Forecast to 2028
The content delivery network market size is projected to reach USD 36.5 billion by 2028, at a CAGR of 10.9% during the forecast period. The major vendors covered in the content delivery network market include Akamai Technologies (US), Microsoft (US), IBM (US), Edgio (US), Google (US), AWS (US), AT&T (US), Cloudflare (US), Lumen Technologies (US), Deutsche Telekom (Germany), Fastly (US), Citrix systems (US), NTT Communications (Japan), Comcast Technologies (US), Rackspace Technology (US), CDNetworks (South Korea), Tata Communications (India), Imperva (US), Broadpeak (France), Quantil (US), StackPath (US), G Core Labs SA (Luxembourg), Tencent Cloud (China), OnApp Limited (UK),EVG Corp (Vietnam), Kingsoft Cloud (China), Bunny.net (Slovenia) and Baishan Cloud (US).
- Published: July 2023
- Price: $ 7150
- TOC Available:
-
Delivery Drones Market by Solution (Platform (Fixed Wing, Multirotor, Fixed Wing VTOL), Software (Route Planning & Optimizing, Live Tracking, Camera Vision, Inventory Management, Fleet Management), Infrastructure (Ground Control Station, Charging Station, Landing Pad, Micro-Fulfillment Centre)], End User [Retail & Food (E-Commerce Package Delivery, Restaurant Package Delivery, Store Package Delivery), Postal & Logistics (Postal Delivery, Parcel Delivery), Healthcare & Pharmacy (Medicine Supply, Blood Supply, Organ Transport, Equipment Transport)), Range (Short Range, Medium Range, Long Range), Payload Capacity (<5 Kilograms, 5-10 Kilograms, >10 Kilograms), Speed (>100 Km/Hour, 100-150 Km/Hour, >150 Km/Hour) and Region - Global Forecast to 2030
Exhaustive secondary research was undertaken to obtain information on the delivery drones market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing by industry experts across the value chain through primary research. Both, top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the size of segments and subsegments.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030
The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2025 to 2030, culminating in a forecasted valuation of US$379.17 billion by the end of the period. The increasing prevalence of chronic diseases worldwide, coupled with the introduction and approval of innovative advanced therapeutics, is driving significant market expansion.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Life Science Analytics Market by Type (Descriptive, Prescriptive, Predictive), by Service (Analytics), Application (Drug Discovery, Trials, RWE, Access, Sales & Marketing, Drug Safety), End User (Pharma, Medical Device) & Region - Global Forecast to 2030
Global life science analytics market valued at $35.69B in 2024, reached $40.03B in 2025, and is projected to grow at a robust 11.4% CAGR, hitting $68.81B by 2030. Emerging technologies like artificial intelligence (AI), quantum computing, and cognitive computing play a vital role in transforming large volumes of raw data into actionable insights.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Glioblastoma Multiforme Drug Market by Therapy (Chemotherapy, Immunotherapy), Drug Class, End Use, Region (North America, Europe, Asia Pacific, and Rest of the World) – Global Forecast to 2027
The global glioblastoma multiforme drug market is projected to reach USD ~880 million by 2027 from USD 600 million in 2022, at a CAGR of 8% during the forecast period
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Drug Screening Market Size by Product (Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)), Sample (Urine, Breath, Hair), Drug (Alcohol, Cannabis, Opioids), End User (Workplace, Hospital, Law) - Global Forecast to 2029
The global drug screening market, valued at US$7.7 billion in 2023, stood at US$9.1 billion in 2024 and is projected to advance at a resilient CAGR of 16.6% from 2024 to 2029, culminating in a forecasted valuation of US$19.5 billion by the end of the period. The growth of the drug screening market is driven by the growing drug & alcohol consumption and the enforcement of stringent laws mandating drug & alcohol testing.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Contract Manufacturing Market by Service (Manufacturing, Fill-Finish), Type (Drug Substance, Drug Product), Scale (Clinical), Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecast to 2030
The global biopharmaceutical contract manufacturing market, valued at US$20.51 billion in 2024, stood at US$22.40 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$34.15 billion by the end of the period. The growth is primarily driven by the rising demand for outsourcing services and an increasing need for biologics and biosimilars. However, challenges related to intellectual property rights are anticipated to pose barriers to market growth.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Therapeutic Drug Monitoring Market by Product (Equipments,Consumables), Technology (Immunoassays), Drug Class (Anti–Epileptic Drugs,Anti–Arrhythmic Drugs), Therapeutic Area (Oncology, Cardiology), Specimen (Blood), End user - Global Forecast to 2029
The global therapeutic drug monitoring market, valued at US$2.14 billion in 2023, stood at US$2.30 billion in 2024 and is projected to advance at a resilient CAGR of 8.4% from 2024 to 2029, culminating in a forecasted valuation of US$3.44 billion by the end of the period. This growth is brought on by a number of causes, such as the rise in chronic diseases like cancer, heart disease, epilepsy, and autoimmune conditions.
- Published: December 2024
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
